Maxcyte (MXCT) Non-Current Assets (2020 - 2026)

Maxcyte (MXCT) has 7 years of Non-Current Assets data on file, last reported at $71.5 million in Q1 2026.

• Non-Current Assets for Q1 2026 came in at $71.5 million, down 3.61% year-over-year; the trailing twelve-month figure through Mar 2026 was $321.0 million (up 9.36% YoY), and the FY2025 annual result was $84.1 million, up 24.12% from the prior year.
• Non-Current Assets eased to $71.5 million in Q1 2026 per MXCT's latest filing, from $84.1 million in the prior quarter.
• Over five years, Non-Current Assets peaked at $88.8 million in Q3 2025 and troughed at $25.2 million in Q1 2022.
• A 5-year average of $60.0 million and a median of $71.5 million in 2026 frame the typical range for Non-Current Assets.
• The sharpest annual moves came in 2022 and 2024: Non-Current Assets soared 318.61% in 2022, then declined 13.18% in 2024.
• A 5-year view of Non-Current Assets shows it stood at $34.4 million in 2022, then surged by 127.06% to $78.1 million in 2023, then retreated by 13.18% to $67.8 million in 2024, then grew by 24.12% to $84.1 million in 2025, then decreased by 14.98% to $71.5 million in 2026.
• Business Quant data shows MXCT's Non-Current Assets at $71.5 million in Q1 2026, $84.1 million in Q4 2025, and $88.8 million in Q3 2025.